Literature DB >> 15515128

Comparison of three expression systems for heterologous xylanase production by S. cerevisiae in defined medium.

Johann F Görgens1, Jordi Planas, Willem H van Zyl, Johannes H Knoetze, Bärbel Hahn-Hägerdal.   

Abstract

The influence of the auxotrophic deficiencies of the host strain and expression vector selection on the production of a heterologous protein was investigated. Heterologous xylanase production by two prototrophic S. cerevisiae transformants, containing either a plasmid-based, YEp-type expression system or an integrative, YIp-type expression system, were compared with production by an auxotrophic transformant, containing an identical YEp-type expression system, in batch and continuous cultivation, using a chemically defined medium. Heterologous xylanase production by the auxotrophic strains in defined medium was critically dependent on the availability of amino acids, as extracellular xylanase production increased dramatically when amino acids were over-consumed from the medium to the point of saturating the cell. Saturation with amino acids, indicated by an increased leakage of amino acids from the cell, was thus a prerequisite for high level of heterologous protein production by the auxotrophic strain. Maximal xylanase production levels by the auxotrophic strain corresponded to the levels obtained with a similar prototrophic strain during cultivation in defined medium without amino acids. Superfluous auxotrophic markers thus had a strong deleterious effect on heterologous protein production by recombinant yeasts, and the use of such strains should be limited to initial exploratory investigations. The increased copy number and foreign gene dosage of the YEp-based expression vector, stabilized by the ura3 fur1 autoselection system, significantly improved production levels of heterologous xylanase, compared to the YIp system, which is based on a single integration into the yeast genome. No evidence was found of the possible saturation of the host secretory capacity by multicopy overexpression. Stable production of heterologous xylanase at high levels by the prototrophic YEp-based recombinant strain, compared to the YIp system, was demonstrated. copyright 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15515128     DOI: 10.1002/yea.1175

Source DB:  PubMed          Journal:  Yeast        ISSN: 0749-503X            Impact factor:   3.239


  6 in total

1.  Transient marker system for iterative gene targeting of a prototrophic fungus.

Authors:  Michael L Nielsen; Willem A de Jongh; Susan L Meijer; Jens Nielsen; Uffe H Mortensen
Journal:  Appl Environ Microbiol       Date:  2007-10-05       Impact factor: 4.792

2.  Quantitative metabolomics analysis of amino acid metabolism in recombinant Pichia pastoris under different oxygen availability conditions.

Authors:  Marc Carnicer; Angela Ten Pierick; Jan van Dam; Joseph J Heijnen; Joan Albiol; Walter van Gulik; Pau Ferrer
Journal:  Microb Cell Fact       Date:  2012-06-15       Impact factor: 5.328

3.  A set of aspartyl protease-deficient strains for improved expression of heterologous proteins in Kluyveromyces lactis.

Authors:  Mehul B Ganatra; Saulius Vainauskas; Julia M Hong; Troy E Taylor; John-Paul M Denson; Dominic Esposito; Jeremiah D Read; Hana Schmeisser; Kathryn C Zoon; James L Hartley; Christopher H Taron
Journal:  FEMS Yeast Res       Date:  2010-12-17       Impact factor: 2.796

4.  Role of cultivation media in the development of yeast strains for large scale industrial use.

Authors:  Bärbel Hahn-Hägerdal; Kaisa Karhumaa; Christer U Larsson; Marie Gorwa-Grauslund; Johann Görgens; Willem H van Zyl
Journal:  Microb Cell Fact       Date:  2005-11-10       Impact factor: 5.328

Review 5.  Trends in recombinant protein use in animal production.

Authors:  Laia Gifre; Anna Arís; Àlex Bach; Elena Garcia-Fruitós
Journal:  Microb Cell Fact       Date:  2017-03-04       Impact factor: 5.328

6.  Current awareness on yeast.

Authors: 
Journal:  Yeast       Date:  2005-01-30       Impact factor: 3.239

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.